In summary, our findings show that KDELR1 is upregulated in gliomas compared with normal brain tissues and that its expression is significantly associated with clinical features such as the WHO grade, recurrence, molecular classification, IDH mutation, and 1p/19q codeletion status. The gene discussed is KDELR1; the disease is central nervous system cancer.